Related Experiment Video
Updated: Feb 3, 2026

Experimental Models to Study the Neuroprotection of Acidic Postconditioning Against Cerebral Ischemia
Published on: July 31, 2017
Taurine Treatment Provides Neuroprotection in a Mouse Model of Manganism
Mohammad Mehdi Ommati1, Reza Heidari2, Vahid Ghanbarinejad1,3
1Pharmaceutical Sciences Research Center, Shiraz University of Medical Sciences, P. O. Box 158371345, Roknabad, Karafarin St., Shiraz, Fars, Iran.
Abstract:
Manganese (Mn) is a trace element involved in many physiological processes. However, excessive Mn exposure leads to neurological complications. Although no precise mechanism(s) has been found for Mn-induced neurotoxicity, oxidative stress and mitochondrial injury seem to play a relevant role in this complication. On the other hand, there is no protective strategy against Mn neurotoxicity so far. Taurine is an amino acid with significant neuroprotective properties. The current study was designed to evaluate the effect of taurine supplementation and its potential mechanism(s) of action in a mouse model of manganism. Animals were treated with Mn (100 mg/kg, s.c) alone and/or in combination with taurine (50, 100, and 500 mg/kg, i.p, for eight consecutive days). Severe locomotor dysfunction along with a significant elevation in brain tissue biomarkers of oxidative stress was evident in Mn-exposed mice. On the other hand, it was revealed that mitochondrial indices of functionality were hampered in Mn-treated animals. Taurine supplementation (50, 100, and 500 mg/kg, i.p) alleviated Mn-induced locomotor deficit. Moreover, this amino acid mitigated oxidative stress biomarkers and preserved brain tissue mitochondrial indices of functionality. These data introduce taurine as a potential neuroprotective agent against Mn neurotoxicity. Antioxidative and mitochondria protecting effects of taurine might play a fundamental role in its neuroprotective properties against Mn toxicity.
Insights
Taurine supplementation effectively protected mice against manganese-induced neurotoxicity, reversing motor deficits and mitigating oxidative stress and mitochondrial damage. This highlights taurine
Area of Science:
- Neuroscience
- Toxicology
- Biochemistry
Background:
- Manganese (Mn) is essential but excessive exposure causes neurotoxicity, potentially via oxidative stress and mitochondrial injury.
- Current strategies to prevent Mn neurotoxicity are lacking.
- Taurine, an amino acid, exhibits known neuroprotective effects.
Purpose of the Study:
- To investigate the neuroprotective potential of taurine against manganese toxicity in a mouse model.
- To explore the underlying mechanisms of taurine's protective effects, focusing on oxidative stress and mitochondrial function.
Main Methods:
- Mice were exposed to manganese (100 mg/kg) and co-treated with varying doses of taurine (50, 100, 500 mg/kg) for eight days.
- Locomotor activity was assessed.
- Brain tissue biomarkers of oxidative stress and mitochondrial function were analyzed.
Main Results:
- Manganese exposure induced significant locomotor dysfunction and increased oxidative stress markers in the brain.
- Mitochondrial function was impaired in manganese-exposed mice.
- Taurine supplementation dose-dependently ameliorated locomotor deficits, reduced oxidative stress, and preserved mitochondrial function.
Conclusions:
- Taurine demonstrates significant neuroprotective effects against manganese-induced toxicity in mice.
- Taurine's benefits may stem from its antioxidant properties and ability to protect mitochondrial function.
- Taurine represents a potential therapeutic strategy for manganese neurotoxicity.
More Related Videos
07:46In vivo Imaging and Therapeutic Treatments in an Orthotopic Mouse Model of Ovarian Cancer
Published on: August 17, 2010
08:53Assessing Neuroprotective Effects of Glycyrrhizae Radix et Rhizoma Extract Using a Transient Middle Cerebral Artery Occlusion Mouse Model
Published on: December 9, 2018
Related Concept Videos
Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
Open Angle Glaucoma: Treatment
Drugs such as carbonic anhydrase inhibitors, α2- and...
Treatment Resistant Cancers
Parkinson's Disease: Treatment
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
Alzheimer's Disease: Treatment
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...